Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
Clinical trial NCT01294774 · COMPLETED
Trial details
- NCT number
- NCT01294774
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.